Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies

References

• Davies AP, Chalmers RM. Cryptosporidiosis. BMJ339, b4168 (2009).
   Google Scholar
• Smith HV, Nichols RA, Mallon M et al. Natural Cryptosporidium hominis infections in Scottish cattle. Vet. Rec.156, 710–711 (2005).
   PubMed Web of Science ®Google Scholar
• Current WL, Reese NC. A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. J. Protozool.33, 98–108 (1986).
   PubMedGoogle Scholar
• Chen XM, Keithly JS, Paya CV, LaRusso NF. Cryptosporidiosis. N. Engl. J. Med.346, 1723–1731 (2002).
   PubMed Web of Science ®Google Scholar
• Amadi B, Mwiya M, Sianongo S et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect. Dis.9, 195 (2009).
   PubMed Web of Science ®Google Scholar
• Macdonald TT, Monteleone I, Fantini MC, Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology140, 1768–1775 (2011).
   PubMed Web of Science ®Google Scholar
• Mowatt AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol.3, 331–341 (2003).
   Google Scholar
• Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc. Natl Acad. Sci. USA108(Suppl. 1), 4607–4614 (2011).
   PubMed Web of Science ®Google Scholar
• Dotan I, Allez M, Nakazawa A, Brimnes J, Schulder-Katz M, Mayer L. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-γ. Am. J. Physiol. Gastrointest. Liver Physiol.292, G1630–G1640 (2007).
   PubMed Web of Science ®Google Scholar
• Mennechet FJ, Kasper LH, Rachinel N et al. Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen. J. Immunol.168, 2988–2996 (2002).
   Google Scholar
• Rescigno M. Dendritic cells in bacteria handling in the gut. J. Leukoc. Biol. DOI: 10.1189/jlb.0311141 (2011) (Epub ahead of print).
   Google Scholar
• Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand. J. Immunol.70, 505–515 (2009).
   PubMed Web of Science ®Google Scholar
• Marcial MA, Madara JL. Cryptosporidium: cellular localization, structural analysis of absorptive cell–parasite membrane–membrane interactions in guinea pigs, and suggestion of protozoan transport by M cells. Gastroenterology90, 583–594 (1986).
   PubMed Web of Science ®Google Scholar
• Laurent F, Eckmann L, Savidge TC et al. Cryptosporidium parvum infection of human intestinal epithelial cells induces polarized secretion of C-X-C chemokines. Infect. Immun.65, 5067–5073 (1997).
   PubMed Web of Science ®Google Scholar
• Chen XM, Levine SA, Splinter PL et al. Cryptosporidium parvum activates nuclear factor κB in biliary epithelia preventing epithelial cell apoptosis. Gastroenterology120, 1774–1783 (2001).
   PubMedGoogle Scholar
• Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V. Differential regulation of β-defensin gene expression during Cryptosporidium parvum infection. Infect. Immun.72, 2772–2779 (2004).
   PubMedGoogle Scholar
• Auray G, Lacroix-Lamande S, Mancassola R, Dimier-Poisson I, Laurent F. Involvement of intestinal epithelial cells in dendritic cell recruitment during Cryptosporidium parvum infection. Microbes Infect.9, 574–582 (2007).
   PubMedGoogle Scholar
• Chen XM, O’Hara SP, Nelson JB et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-κB. J. Immunol.175, 7447–7456 (2005).
   PubMed Web of Science ®Google Scholar
• O’Hara SP, Chen XM. The cell biology of Cryptosporidium infection. Microbes Infect.13, 721–730 (2011).
   PubMed Web of Science ®Google Scholar
• Yang YL, Buck GA, Widmer G. Cell sorting-assisted microarray profiling of host cell response to Cryptosporidium parvum infection. Infect. Immun.78, 1040–1048 (2010).
   Google Scholar
• Pollok RC, Farthing MJ, Bajaj-Elliott M, Sanderson IR, McDonald V. Interferon γ induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology120, 99–107 (2001).
   PubMedGoogle Scholar
• Choudhry N, Korbel DS, Edwards LA, Bajaj-Elliott M, McDonald V. Dysregulation of interferon-γ-mediated signalling pathway in intestinal epithelial cells by Cryptosporidium parvum infection. Cell Microbiol.11, 1354–1364 (2009).
   Google Scholar
• Heine J, Moon HW, Woodmansee DB. Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect. Immun.43, 856–859 (1984).
   PubMedGoogle Scholar
• McDonald V, Deer R, Uni S, Iseki M, Bancroft GJ. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect. Immun.60, 3325–3331 (1992).
   Google Scholar
• Miller TA, Ware MW, Wymer LJ, Schaefer FW III. Chemically and genetically immunocompromised mice are not more susceptible than immunocompetent mice to infection with Cryptosporidium muris. Vet. Parasitol.143, 99–105 (2007).
   Google Scholar
• Kuhls TL, Mosier DA, Abrams VL, Crawford DL, Greenfield RA. Inability of interferon-γ and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency. J. Parasitol.80, 480–485 (1994).
   Google Scholar
• Barakat FM, McDonald V, Di Santo JP, Korbel DS. Roles for NK cells and an NK cell-independent source of intestinal γ interferon for innate immunity to Cryptosporidium parvum infection. Infect. Immun.77, 5044–5049 (2009).
   Google Scholar
• McDonald V, Robinson HA, Kelly JP, Bancroft GJ. Cryptosporidium muris in adult mice: adoptive transfer of immunity and protective roles of CD4 versus CD8 cells. Infect. Immun.62, 2289–2294 (1994).
   Google Scholar
• Tzipori S. Cryptosporidiosis in perspective. Adv. Parasitol.27, 63–129 (1988).
   PubMedGoogle Scholar
• Kutukculer N, Moratto D, Aydinok Y et al. Disseminated Cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J. Pediatr.142, 194–196 (2003).
   Google Scholar
• Cosyns M, Tsirkin S, Jones M, Flavell R, Kikutani H, Hayward AR. Requirement of CD40–CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect. Immun.66, 603–607 (1998).
   PubMed Web of Science ®Google Scholar
• Waters WR, Harp JA. Cryptosporidium parvum infection in T-cell receptor (TCR)-α- and TCR-δ-deficient mice. Infect. Immun.64, 1854–1857 (1996).
   Google Scholar
• Eichelberger MC, Suresh P, Rehg JE. Protection from Cryptosporidium parvum infection by γδ T cells in mice that lack αβ T cells. Comp Med.50, 270–276 (2000).
   Google Scholar
• Abrahamsen MS, Lancto CA, Walcheck B, Layton W, Jutila MA. Localization of α/β and γ/δ T lymphocytes in Cryptosporidium parvum-infected tissues in naive and immune calves. Infect. Immun.65, 2428–2433 (1997).
   Google Scholar
• Aguirre SA, Mason PH, Perryman LE. Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection. Infect. Immun.62, 697–699 (1994).
   Google Scholar
• Ungar BL, Kao TC, Burris JA, Finkelman FD. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-γ and CD4+ T lymphocytes in protective immunity. J. Immunol.147, 1014–1022 (1991).
   PubMed Web of Science ®Google Scholar
• Chen W, Harp JA, Harmsen AG. Requirements for CD4+ cells and γ interferon in resolution of established Cryptosporidium parvum infection in mice. Infect. Immun.61, 3928–3932 (1993).
   PubMed Web of Science ®Google Scholar
• Blanshard C, Jackson AM, Shanson DC, Francis N, Gazzard BG. Cryptosporidiosis in HIV-seropositive patients. QJ Med.85, 813–823 (1992).
   PubMedGoogle Scholar
• Schmidt W, Wahnschaffe U, Schafer M et al. Rapid increase of mucosal CD4+ T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy. Gastroenterology120, 984–987 (2001).
   PubMed Web of Science ®Google Scholar
• Singh I, Carville A, Tzipori S. Cryptosporidiosis in rhesus macaques challenged during acute and chronic phases of SIV infection. AIDS Res. Hum. Retroviruses27(9), 989–997 (2011).
   Google Scholar
• Harp JA, Whitmire WM, Sacco R. In vitro proliferation and production of γ interferon by murine CD4+ cells in response to Cryptosporidium parvum antigen. J. Parasitol.80, 67–72 (1994).
   Google Scholar
• McDonald V, Robinson HA, Kelly JP, Bancroft GJ. Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes. Infect. Immun.64, 2556–2562 (1996).
   PubMedGoogle Scholar
• Culshaw RJ, Bancroft GJ, McDonald V. Gut intraepithelial lymphocytes induce immunity against Cryptosporidium infection through a mechanism involving γ interferon production. Infect. Immun.65, 3074–3079 (1997).
   PubMed Web of Science ®Google Scholar
• Ungar BL, Burris JA, Quinn CA, Finkelman FD. New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect. Immun.58, 961–969 (1990).
   Google Scholar
• McDonald V, Bancroft GJ. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol.16, 315–320 (1994).
   PubMedGoogle Scholar
• Leav BA, Yoshida M, Rogers K et al. An early intestinal mucosal source of γ interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice. Infect. Immun.73, 8425–8428 (2005).
   PubMedGoogle Scholar
• Pantenburg B, Castellanos-Gonzalez A, Dann SM et al. Human CD8+ T cells clear Cryptosporidium parvum from infected intestinal epithelial cells. Am. J. Trop. Med. Hyg.82, 600–607 (2010).
   PubMedGoogle Scholar
• Kirkpatrick BD, Haque R, Duggal P et al. Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles. J. Infect. Dis.197, 474–478 (2008).
   Google Scholar
• Kapel N, Benhamou Y, Buraud M, Magne D, Opolon P, Gobert JG. Kinetics of mucosal ileal γ-interferon response during cryptosporidiosis in immunocompetent neonatal mice. Parasitol. Res.82, 664–667 (1996).
   Google Scholar
• Fayer R, Gasbarre L, Pasquali P, Canals A, Almeria S, Zarlenga D. Cryptosporidium parvum infection in bovine neonates: dynamic clinical, parasitic and immunologic patterns. Int. J. Parasitol.28, 49–56 (1998).
   PubMed Web of Science ®Google Scholar
• Wyatt CR, Brackett EJ, Savidge J. Evidence for the emergence of a type-1-like immune response in intestinal mucosa of calves recovering from cryptosporidiosis. J. Parasitol.87, 90–95 (2001).
   Google Scholar
• Gomez Morales MA, La Rosa G, Ludovisi A, Onori AM, Pozio E. Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis. J. Infect. Dis.179, 967–973 (1999).
   PubMedGoogle Scholar
• White AC, Robinson P, Okhuysen PC et al. Interferon-γ expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J. Infect. Dis.181, 701–709 (2000).
   Google Scholar
• Mead JR, You X. Susceptibility differences to Cryptosporidium parvum infection in two strains of γ interferon knockout mice. J. Parasitol.84, 1045–1048 (1998).
   Google Scholar
• Jakobi V, Petry F. Humoral immune response in IL-12 and IFN-γ deficient mice after infection with Cryptosporidium parvum. Parasite Immunol.30, 151–161 (2008).
   PubMedGoogle Scholar
• Aguirre SA, Perryman LE, Davis WC, McGuire TC. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+α β+IFN-γ+ and CD4+α β+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection. J. Immunol.161, 1891–1900 (1998).
   Google Scholar
• Tessema TS, Dauber E, Petry F. Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-γ and interleukin-12-deficient mice to naive recipients. Vaccine27, 6575–6581 (2009).
   Google Scholar
• McDonald SA, O’Grady JE, Bajaj-Elliott M et al. Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines. J. Infect. Dis.190, 1019–1025 (2004).
   Google Scholar
• Urban JF Jr, Fayer R, Chen SJ, Gause WC, Gately MK, Finkelman FD. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J. Immunol.156, 263–268 (1996).
   PubMed Web of Science ®Google Scholar
• Ehigiator HN, Romagnoli P, Borgelt K et al. Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice. Parasite Immunol.27, 17–28 (2005).
   PubMedGoogle Scholar
• Ehigiator HN, McNair N, Mead JR. Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice. Exp. Parasitol.115, 107–113 (2007).
   PubMed Web of Science ®Google Scholar
• Tessema TS, Schwamb B, Lochner M, Forster I, Jakobi V, Petry F. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-γ and interleukin-12p40 knockout mice during primary and challenge Cryptosporidium parvum infection. Immunobiology214, 454–466 (2009).
   PubMedGoogle Scholar
• Smith LM, Bonafonte MT, Campbell LD, Mead JR. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in γ interferon knockout mice. Exp. Parasitol.98, 123–133 (2001).
   Google Scholar
• Davami MH, Bancroft GJ, McDonald V. Cryptosporidium infection in major histocompatibility complex congeneic strains of mice: variation in susceptibility and the role of T-cell cytokine responses. Parasitol. Res.83, 257–263 (1997).
   Google Scholar
• Enriquez FJ, Sterling CR. Role of CD4+ Th1- and Th2-cell-secreted cytokines in cryptosporidiosis. Folia Parasitol. (Praha)40, 307–311 (1993).
   Google Scholar
• Lacroix S, Mancassola R, Naciri M, Laurent F. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and γ interferon-deficient mice: role of tumor necrosis factor α in protection. Infect. Immun.69, 1635–1642 (2001).
   Google Scholar
• Lean IS, McDonald SA, Bajaj-Elliott M, Pollok RC, Farthing MJ, McDonald V. Interleukin-4 and transforming growth factor β have opposing regulatory effects on γ interferon-mediated inhibition of Cryptosporidium parvum reproduction. Infect. Immun.71, 4580–4585 (2003).
   Google Scholar
• Mead JR, Arrowood MJ, Sidwell RW, Healey MC. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J. Infect. Dis.163, 1297–1304 (1991).
   PubMed Web of Science ®Google Scholar
• Chen W, Harp JA, Harmsen AG, Havell EA. γ interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infect. Immun.61, 3548–3551 (1993).
   Web of Science ®Google Scholar
• Hayward AR, Chmura K, Cosyns M. Interferon-γ is required for innate immunity to Cryptosporidium parvum in mice. J. Infect. Dis.182, 1001–1004 (2000).
   PubMedGoogle Scholar
• McDonald V, Smith R, Robinson H, Bancroft G. Host immune responses against Cryptosporidium. Contrib. Microbiol.6, 75–91 (2000).
   Google Scholar
• Takeuchi D, Jones VC, Kobayashi M, Suzuki F. Cooperative role of macrophages and neutrophils in host antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum. Infect. Immun.76, 3657–3663 (2008).
   Google Scholar
• Korbel DS, Barakat FM, Di Santo JP, McDonald V. CD4+ T cells are not essential for control of early acute Cryptosporidium parvum infection in neonatal mice. Infect. Immun.79, 1647–1653 (2011).
   Google Scholar
• Mancassola R, Lacroix-Lamande S, Barrier M, Naciri M, Salmon H, Laurent F. Increased susceptibility of β7-integrin-deficient neonatal mice in the early stage of Cryptosporidium parvum infection. Infect. Immun.72, 3634–3637 (2004).
   Google Scholar
• Barakat FM, McDonald V, Foster GR, Tovey MG, Korbel DS. Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon. J. Infect. Dis.200, 1548–1555 (2009).
   PubMedGoogle Scholar
• Zhao J, Kim KD, Yang X, Auh S, Fu YX, Tang H. Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proc. Natl Acad. Sci. USA105, 7528–7533 (2008).
   PubMed Web of Science ®Google Scholar
• Rogers KA, Rogers AB, Leav BA et al. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice. Infect. Immun.74, 549–556 (2006).
   Google Scholar
• Barrier M, Lacroix-Lamande S, Mancassola R et al. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice. J. Infect. Dis.193, 1400–1407 (2006).
   PubMed Web of Science ®Google Scholar
• Ungar BL, Soave R, Fayer R, Nash TE. Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons. J. Infect. Dis.153, 570–578 (1986).
   PubMed Web of Science ®Google Scholar
• Peeters JE, Villacorta I, Vanopdenbosch E et al. Cryptosporidium parvum in calves: kinetics and immunoblot analysis of specific serum and local antibody responses (immunoglobulin A [IgA], IgG, and IgM) after natural and experimental infections. Infect. Immun.60, 2309–2316 (1992).
   Google Scholar
• Hill BD, Blewett DA, Dawson AM, Wright S. Analysis of the kinetics, isotype and specificity of serum and coproantibody in lambs infected with Cryptosporidium parvum. Res. Vet. Sci.48, 76–81 (1990).
   Google Scholar
• Priest JW, Bern C, Xiao L et al. Longitudinal analysis of cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children. Clin. Vaccine Immunol.13, 123–131. (2006).
   Google Scholar
• Cozon G, Biron F, Jeannin M, Cannella D, Revillard JP. Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. J. Infect. Dis.169, 696–699 (1994).
   Google Scholar
• Frost FJ, Tollestrup K, Craun GF, Fairley CK, Sinclair MI, Kunde TR. Protective immunity associated with a strong serological response to a Cryptosporidium-specific antigen group, in HIV-infected individuals. J. Infect. Dis.192, 618–621 (2005).
   Google Scholar
• Albert MM, Rusnak J, Luther MF, Graybill JR. Treatment of murine cryptosporidiosis with anticryptosporidial immune rat bile. Am. J. Trop. Med. Hyg.50, 112–119 (1994).
   Google Scholar
• Enriquez FJ, Riggs MW. Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection. Infect. Immun.66, 4469–4473 (1998).
   Google Scholar
• Taghi-Kilani R, Sekla L, Hayglass KT. The role of humoral immunity in Cryptosporidium spp. infection. Studies with B cell-depleted mice. J. Immunol.145, 1571–1576 (1990).
   Google Scholar
• Chen W, Harp JA, Harmsen AG. Cryptosporidium parvum infection in gene-targeted B cell-deficient mice. J. Parasitol.89, 391–393 (2003).
   Google Scholar
• Tzipori S, Roberton D, Cooper DA, White L. Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet2, 344–345 (1987).
   PubMed Web of Science ®Google Scholar
• Fayer R, Andrews C, Ungar BL, Blagburn B. Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. J. Parasitol.75, 393–397 (1989).
   PubMed Web of Science ®Google Scholar
• Fayer R, Perryman LE, Riggs MW. Hyperimmune bovine colostrum neutralizes Cryptosporidium sporozoites and protects mice against oocyst challenge. J. Parasitol.75, 151–153 (1989).
   Google Scholar
• Jenkins M, Kerr D, Fayer R, Wall R. Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encoding a Cryptosporidium parvum antigen. Vaccine13, 1658–1664 (1995).
   PubMedGoogle Scholar
• Sagodira S, Buzoni-Gatel D, Iochmann S, Naciri M, Bout D. Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA. Vaccine17, 2346–2355 (1999).
   PubMedGoogle Scholar
• Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin. Infect. Dis.26, 1324–1329 (1998).
   PubMed Web of Science ®Google Scholar
• Schaefer DA, Auerbach-Dixon BA, Riggs MW. Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis. Infect. Immun.68, 2608–2616 (2000).
   PubMedGoogle Scholar
• McDonald V, Shirley MW. Past and future: vaccination against Eimeria. Parasitology136, 1477–1489 (2009).
   PubMed Web of Science ®Google Scholar
• Jenkins M, Higgins J, Kniel K, Trout J, Fayer R. Protection of calves against cryptosporiosis by oral inoculation with γ-irradiated Cryptosporidium parvum oocysts. J. Parasitol.90, 1178–1180 (2004).
   PubMedGoogle Scholar
• Boulter-Bitzer JI, Lee H, Trevors JT. Molecular targets for detection and immunotherapy in Cryptosporidium parvum. Biotechnol. Adv.25, 13–44 (2007).
   PubMedGoogle Scholar
• Ehigiator HN, Romagnoli P, Priest JW, Secor WE, Mead JR. Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum. Parasitol. Res.101, 943–950 (2007).
   PubMedGoogle Scholar
• Zheng J, Ren W, Pan Q et al. A recombinant DNA vaccine encoding Cryptosporidium andersoni oocyst wall protein induces immunity against experimental C. parvum infection. Vet. Parasitol.179, 7–13 (2011).
   Google Scholar
• Pasetti MF, Simon JK, Sztein MB, Levine MM. Immunology of gut mucosal vaccines. Immun. Rev.239, 125–148 (2011).
   PubMed Web of Science ®Google Scholar
• Hammerschmidt SI, Friedrichsen M, Boelter J et al. Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice. J. Clin. Invest.121(8), 3051–3061 (2011).
   PubMed Web of Science ®Google Scholar
• Gooi HC. Gastrointestinal and liver involvement in primary immunodeficiency. In: Gastrointestinal and Hepatic Immunology. Healey HV (Ed.). Cambridge University Press, Cambridge, UK, 169–177 (1994).
   Google Scholar
• Ungar BL, Ward DJ, Fayer R, Quinn CA. Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology98, 486–489 (1990).
   PubMedGoogle Scholar
• Xu P, Widmer G, Wang Y et al. The genome of Cryptosporidium hominis. Nature431, 1107–1112 (2004).
   PubMed Web of Science ®Google Scholar